# PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder

> **NCT06452290** · NA · NOT_YET_RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 30 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DEVICE:** brain 18F-FDG PET-CT

## Key facts

- **NCT ID:** NCT06452290
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-09-01
- **Final completion:** 2029-03-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06452290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06452290, "PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06452290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*